Automatic external defibrillators
This article was originally published in The Gray Sheet
Inappropriate administration of shocks by untrained good Samaritans "have not been a problem because the devices contain sophisticated rhythm-detection algorithms," an editorial accompanying an Oct. 17 New England Journal of Medicine study on public AED use comments. "Without federal deregulation, the current requirements for prescription, oversight and formal training are major roadblocks." The two-year, observational study suggested that AEDs in well-marked public areas at Chicago airports were effectively used to treat cardiac arrest...
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.